RxDoctor Payments Data

Christina Rariden

Family · Farmington, MONPI 1881854354

Payments from drug & device makers

$4,360in general payments, 2019–2025

Across 29 payments — averaging $150.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$4K
  • AbbVie$318
  • Otsuka America Pharmaceutical, Inc.$123
  • Alkermes, Inc.$106
  • Neurocrine Biosciences, Inc.$66
  • Axsome Therapeutics, Inc.$65
  • plus $126 from 4 others

What the payments were for

  • Speaking & faculty fees$3,22574%
  • Travel & lodging$130%
  • Food & beverage$1,01023%
  • Education$1113%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,360 in reported general payments places this provider in the 90th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$3,945
Medicare patients
14
Services billed
42

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine19$222,094
RexultiBrexpiprazole16$22,715
Lurasidone Hcl21$2,909
Aripiprazole73$1,453
Duloxetine Hcl85$1,187
Hydroxyzine Pamoate88$953
Bupropion XlBupropion Hcl52$844
Vilazodone Hcl12$777
Buspirone Hcl69$701
Trazodone Hcl113$680
Haloperidol18$644
Benztropine Mesylate51$570
Haloperidol Decanoate13$561
Mirtazapine44$557
Venlafaxine Hcl ErVenlafaxine Hcl65$546

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$3,557$222,09419 claims
Otsuka America Pharmaceutical, Inc.Rexulti$123$22,71516 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,812 family providers in Missouri.

Other family in Farmington

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →